Pacer Advisors, Inc. Myriad Genetics Inc Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 532 shares of MYGN stock, worth $14,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
532
Previous 1,160
54.14%
Holding current value
$14,715
Previous $24,000
45.83%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MYGN
# of Institutions
232Shares Held
92.6MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$419 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$278 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$229 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$152 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$122 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.23B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...